HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Stockley Selected Research

Neoplasms (Cancer)

1/2022Identification and optimization of a novel series of selective PIP5K inhibitors.
1/2021Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance.
12/2016Quantitative Chemical Proteomic Profiling of Ubiquitin Specific Proteases in Intact Cancer Cells.
11/2016Discovery of potent inhibitors of the lysophospholipase autotaxin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin Stockley Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 11/2016
1Inflammation (Inflammations)
11/2016
1Fibrosis (Cirrhosis)
11/2016

Drug/Important Bio-Agent (IBA)

1Phosphotransferases (Kinase)IBA
01/2022
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2022
1LipidsIBA
01/2022
1DNA-Directed DNA Polymerase (Polymerases, DNA)IBA
01/2021
1Ubiquitin-Specific ProteasesIBA
12/2016
1lysophosphatidic acidIBA
11/2016